MFG
AMRX icon

MidWestOne Financial Group’s Amneal Pharmaceuticals AMRX Stock Holding History

MidWestOne Financial Group’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$178K Sell
14,142
-1,370
-9% -$15.7K 0.02% 302
2025
Q3 		$155K Sell
15,512
-152
-1% -$1.36K 0.02% 300
2025
Q2 		$127K Buy
+15,664
New +$118K 0.02% 292

Other funds holding AMRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

MidWestOne Financial Group's AMRX Position: Q4 2025 in Review

MidWestOne Financial Group reduced its Amneal Pharmaceuticals (AMRX) stake by 8.8% in Q4 2025, selling an estimated $15.7K and leaving 14,142 shares worth $178K. The position accounts for 0.02% of the portfolio, ranked #302.

MidWestOne Financial Group first reported a position in AMRX in Q2 2025 and has held it in 3 quarters since. 277 funds tracked by Wall St. Rank hold AMRX as of Q4 2025.

  • MidWestOne Financial Group held 14,142 shares of Amneal Pharmaceuticals worth $178K as of Q4 2025.
  • MidWestOne Financial Group sold 1,370 Amneal Pharmaceuticals shares in Q4 2025, an estimated $15.7K.
  • Amneal Pharmaceuticals made up 0.02% of MidWestOne Financial Group's portfolio in Q4 2025, its #302 holding.
  • MidWestOne Financial Group first reported a position in Amneal Pharmaceuticals in Q2 2025 and has held it in 3 quarters since.
  • 277 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q4 2025.

Based on MidWestOne Financial Group's 13F filing for Q4 2025, filed 12 Feb 2026.